Rapid CommunicationMinireview—Molecular Pharmacology in China
Open Access
MG53: Biological Function and Potential as a Therapeutic Target
Yan Zhang, Hong-Kun Wu, Fengxiang Lv and Rui-Ping Xiao
Molecular Pharmacology September 2017, 92 (3) 211-218; DOI: https://doi.org/10.1124/mol.117.108241
Yan Zhang
State Key Laboratory of Membrane Biology, Institute of Molecular Medicine (Y.Z., H.-K.W., F.L., R.-P.X.), Peking-Tsinghua Center for Life Sciences (R.-P.X.), and Beijing City Key Laboratory of Cardiometabolic Molecular Medicine (R.-P.X.), Peking University, Beijing, China
Hong-Kun Wu
State Key Laboratory of Membrane Biology, Institute of Molecular Medicine (Y.Z., H.-K.W., F.L., R.-P.X.), Peking-Tsinghua Center for Life Sciences (R.-P.X.), and Beijing City Key Laboratory of Cardiometabolic Molecular Medicine (R.-P.X.), Peking University, Beijing, China
Fengxiang Lv
State Key Laboratory of Membrane Biology, Institute of Molecular Medicine (Y.Z., H.-K.W., F.L., R.-P.X.), Peking-Tsinghua Center for Life Sciences (R.-P.X.), and Beijing City Key Laboratory of Cardiometabolic Molecular Medicine (R.-P.X.), Peking University, Beijing, China
Rui-Ping Xiao
State Key Laboratory of Membrane Biology, Institute of Molecular Medicine (Y.Z., H.-K.W., F.L., R.-P.X.), Peking-Tsinghua Center for Life Sciences (R.-P.X.), and Beijing City Key Laboratory of Cardiometabolic Molecular Medicine (R.-P.X.), Peking University, Beijing, China
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Rapid CommunicationMinireview—Molecular Pharmacology in China
MG53: Function and Therapeutic Potential
Yan Zhang, Hong-Kun Wu, Fengxiang Lv and Rui-Ping Xiao
Molecular Pharmacology September 1, 2017, 92 (3) 211-218; DOI: https://doi.org/10.1124/mol.117.108241
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement